scorecardresearch
Tuesday, March 26, 2024
Support Our Journalism
HomeHealthSerum Institute seeks DCGI permission to manufacture Sputnik V vaccine

Serum Institute seeks DCGI permission to manufacture Sputnik V vaccine

The SII has already told the government that it will be able to manufacture and supply 10 crore Covishield doses in June and is also manufacturing the Novavax vaccine.

Follow Us :
Text Size:

New Delhi: The Serum Institute of India (SII) has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture COVID-19 vaccine Sputnik V in the country, sources said on Thursday.

The Pune-based firm has also sought approval for test analysis and examination.

Russia’s Sputnik V vaccine is currently being manufactured in India by Dr Reddy’s Laboratories.

“The Serum Institute of India (SII) put up an application to the Drugs Controller General of India (DCGI) on Wednesday seeking permission to manufacture the COVID-19 vaccine, Sputnik V, in India,” a source said.

The SII has already told the government that it will be able to manufacture and supply 10 crore Covishield doses in June, while it is also manufacturing the Novavax vaccine, the regulatory clearance for which is awaited from the United States.

The vaccine was given emergency use authorisation (EUA) by the DCGI in April.

A consignment of 30 lakh doses of Sputnik V landed in Hyderabad on Tuesday.


Also read: Sputnik V arrived 1 May to boost India’s vaccine drive, but is still ‘stuck’ in lab for tests


 

Subscribe to our channels on YouTube, Telegram & WhatsApp

Support Our Journalism

India needs fair, non-hyphenated and questioning journalism, packed with on-ground reporting. ThePrint – with exceptional reporters, columnists and editors – is doing just that.

Sustaining this needs support from wonderful readers like you.

Whether you live in India or overseas, you can take a paid subscription by clicking here.

Support Our Journalism

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular